Assessment of Health-Related Quality of Life in Patients With Overactive Bladder Taking Tolterodine Extended Release Versus Placebo
Khullar V1, Hill S 2, Solanki J3 1. Imperial College, School of Medicine, 2. Queen's Park Hospital, 3. Pfizer, Inc
|
|
Abstract 318
|
|
|
Non Discussion Posters
Scientific Non Discussion Poster Session 17
|
|
|